Literature DB >> 3196478

Prognostic significance of the Ackerman classification and other histopathological characteristics in breast cancer. An analysis of 1,349 consecutive cases with complete follow-up over seven years.

L Holmberg1, H O Adami, A Lindgren, A Ekbom, A Sandström, R Bergström.   

Abstract

Survival rates during a follow-up period of more than seven years were analyzed in 1,349 women with breast cancer in relation to the histo-pathological classification of female breast cancer proposed by Ackerman and to other commonly used histo-pathological criteria, including the axillary node status. The information was collected prospectively during a case-control study. Major emphasis was placed on multivariate evaluation. In analyses based on the histo-pathological findings in the mastectomy specimen alone, the Ackerman grouping was found to be of prognostic value, but apart from nuclear polymorphism the other recorded characteristics (histo-pathological type, histological grading, lymphocyte infiltration, and sinus histiocytosis) did not give any prognostic information. When the axillary node status was included in the multivariate models, the presence of axillary metastases correlated well with the prognosis and the Ackerman classification provided no significant additional information. The results indicate that in cases where the histopathological axillary status is known, little additional prognostic information can be gained from traditional histo-pathological evaluation over and above this status. However, the Ackerman classification and the degree of nuclear polymorphism separate distinct prognostic groups with the same degree of difference in observed survival rates as one discriminated by the axillary node status.

Entities:  

Mesh:

Year:  1988        PMID: 3196478     DOI: 10.1111/j.1699-0463.1988.tb00971.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  5 in total

1.  Mitotic indexes as prognostic predictors in female breast cancer.

Authors:  S Aaltomaa; P Lipponen; M Eskelinen; V M Kosma; S Marin; E Alhava; K Syrjänen
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Effects of lymphocytes and fibroblasts on the growth of human mammary carcinoma cells studied in short-term primary cultures.

Authors:  H M Ogmundsdóttir; I Pétursdóttir; I Gudmundsdóttir; L Amundadóttir; L Rønnov-Jessen; O W Petersen
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-12       Impact factor: 2.416

3.  Prognostic characteristics in breast cancers after hormone replacement therapy.

Authors:  C Magnusson; L Holmberg; T Nordén; A Lindgren; I Persson
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer.

Authors:  Andrew E Teschendorff; Ahmad Miremadi; Sarah E Pinder; Ian O Ellis; Carlos Caldas
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

5.  Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis.

Authors:  Srikanth Nagalla; Jeff W Chou; Mark C Willingham; Jimmy Ruiz; James P Vaughn; Purnima Dubey; Timothy L Lash; Stephen J Hamilton-Dutoit; Jonas Bergh; Christos Sotiriou; Michael A Black; Lance D Miller
Journal:  Genome Biol       Date:  2013-04-29       Impact factor: 13.583

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.